Latka logo

Valuation

$470.8K

2024 Revenue

$2M

Funding

$0

YOY

1,512.1%

Team

1

Founded

2008

How ScopiaRx CEO Jeffrey Huth grew to $2M revenue with a 1 person team in 2024.

At ScopiaRx we make complex medication safety simple. Whether you take 5, 10, or 20 medications ScopiaRx helps you, your caregivers, and your providers make sure those treatments are safe for you.The idea for ScopiaRx came to Dr. Jeffrey Huth while helping a family member manage her 12 different prescriptions. Like millions of patients, the number of her prescriptions kept creeping up to address new chronic conditions and symptoms. One day, a tipping point was reached, and she just did not feel well. Jeff has a deep background in both the science and clinical considerations of medication safety. Despite this, it literally took him hours of work to look up all of the information for 12 medications and compare that to the specific traits of one patient. What he also discovered was that there are millions of case reports about side effects from people just like his family member, but that none of this information was at the finger tips of the doctors who were prescribing her medications.

Last updated

ScopiaRx Revenue

In 2024, ScopiaRx's revenue reached $2M. The company previously reported $156.9K in 2024. Since its launch in 2008, ScopiaRx has shown consistent revenue growth.

ScopiaRx Revenue GrowthReported revenue / ARR over time$0$500K$1M$2M$2M$3M200820102012201420162018202020222024$0$103K$124K$2MSource: GetLatka.com
YearMilestoneQuote
2024ScopiaRx Hit $2m revenue in November 2024Source
2024ScopiaRx Hit $156.9k revenue in October 2024
2023ScopiaRx Hit $124.1k revenue in December 2023
2021ScopiaRx Hit $103.4k revenue in April 2021
2008Launched with $0 revenue

ScopiaRx Valuation, Funding Rounds

ScopiaRx's most recent disclosed valuation is $470.8K.

ScopiaRx is a bootstrapped SaaS startup. Founded in 2008, ScopiaRx has grown to $2M in revenue without raising any venture capital or outside funding.

As a self-funded SaaS company, ScopiaRx has built its business with no outside investment.

ScopiaRx Capital Raised & ValuationCumulative capital raised and post-money valuation by roundCapital raised (cum.)Valuation$0$0$0.2$0.2$0.4$0.4$0.6$0.6$0.8$0.8$1$12008Source: GetLatka.com
YearRoundAmountValuation% SoldQuote

Founder / CEO

Jeffrey Huth

Jeffrey Huth is listed as Founder / CEO at ScopiaRx.

Q&A

QuestionAnswer
What's your age?-
Favorite online tool?-
Favorite book?-
Favorite CEO?-
Advice for 20 year old self-

Customers

We do not have customer count information for ScopiaRx yet.

ScopiaRx Employees & Team Size

ScopiaRx employs approximately 1 people as of 2026.

ScopiaRx Team GrowthReported headcount over time0112232008201020122014201620182020202220240011Source: GetLatka.com
YearMilestone
2024Reached 1 employees (October 2024)
2023Reached 1 employees (December 2023)
2022Reached 1 employees (December 2022)
2021Reached 1 employees (December 2021)
2021Reached 2 employees (April 2021)

Frequently Asked Questions about ScopiaRx

What is ScopiaRx's revenue?

ScopiaRx generates $2M in revenue.

Who founded ScopiaRx?

ScopiaRx was founded by Jeffrey Huth.

Who is the CEO of ScopiaRx?

The CEO of ScopiaRx is Jeffrey Huth.

How much funding does ScopiaRx have?

ScopiaRx raised $0.

How many employees does ScopiaRx have?

ScopiaRx has 1 employees.

Where is ScopiaRx headquarters?

ScopiaRx is headquartered in Cincinnati, Ohio, United States.

Data and Sources

All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.

Claim this profile
ScopiaRx Revenue 2024: $2M ARR, $470.8K Valuation